How does PREA relate to the Best Pharmaceuticals for Children Act (BPCA)?
The Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA) are complementary laws aimed at promoting pediatric drug research. While PREA mandates pediatric studies for certain drugs, BPCA provides incentives, such as extended market exclusivity, for companies that voluntarily conduct pediatric studies. Together, these laws enhance the availability of pediatric drug data and improve medication safety for children.
